Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT)

1.74
BATS BZX Real-Time Price
As of 3:44pm ET
 +0.22 / +14.47%
Today’s Change
0.93
Today|||52-Week Range
2.45
+61.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$56.1M

Company Description

EyePoint Pharmaceuticals, Inc. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and Tethadur is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. The company was founded by Roger Aston in March 2008 and is headquartered in Watertown, MA.

Contact Information

EyePoint Pharmaceuticals, Inc.
480 Pleasant Street
Watertown Massachusetts 02472
P:(617) 926-5000
Investor Relations:

Employees

Shareholders

Mutual fund holders0.00%
Individual stakeholders--
Other institutional--

Top Executives

Nancy Sue LurkerPresident, Chief Executive Officer & Director
Marty NazzaroVice President-Operations
Leonard S. RossChief Accounting Officer & Vice President-Finance
Dario A. PaggiarinoChief Medical Officer & Vice President
Hong GuoVice President-Development